Anavex Life Sciences presents positive long-term results of oral blarcamesine for Alzheimer's patients
From GlobeNewswire: 2025-04-05 11:30:00
Anavex Life Sciences Corp. presented data from the ATTENTION-AD trial at the AD/PDTM 2025 Conference, showing the disease-modifying effect of oral blarcamesine in Alzheimer’s patients after 192 weeks of treatment. The drug exhibited a favorable safety profile with no treatment-related deaths. Results suggest early and continuous long-term treatment may provide significant benefits for early Alzheimer’s disease patients, encouraging uninterrupted treatment for better outcomes. The delayed-start analysis indicated a significant stability of cognitive function in patients who started treatment earlier, supporting the potential disease-modifying characteristics of blarcamesine. Safety data showed manageable adverse events with no severe or life-threatening issues reported. The Compassionate Use Program currently has 74 participants continuing treatment with blarcamesine. Anavex Life Sciences Corp. reports positive results from long-term study of oral blarcamesine for Alzheimer’s disease treatment, with some participants taking the drug for over 9 years without severe adverse events. The CEO highlights the potential for improved quality of life and reduced barriers to healthcare access. The company’s lead drug candidate, ANAVEX®2-73, has shown promise in clinical trials for Alzheimer’s, Parkinson’s, and Rett syndrome. Anavex aims to develop novel therapeutics for neurodegenerative disorders and cancer. The presentation and further information are available on the company’s website. Investors can reach out for more information. 1. The stock market saw a significant increase today, with the Dow Jones Industrial Average rising by 300 points due to positive economic data and strong corporate earnings reports.
2. A new study reveals that eating a plant-based diet can lower the risk of heart disease by 32%. Researchers found that individuals who followed a plant-based diet had lower cholesterol levels and a reduced risk of developing cardiovascular disease.
3. The United Nations reported that over 100,000 children in Ethiopia are facing severe malnutrition due to the ongoing conflict in the Tigray region. Humanitarian aid organizations are working to provide food and medical assistance to those in need.
4. Tesla announced plans to build a new Gigafactory in Texas, which is expected to create thousands of jobs and boost the local economy. The electric car company aims to increase production capacity to meet growing demand for their vehicles.
5. The European Union reached a historic agreement to reduce carbon emissions by 55% by 2030. This ambitious target is part of the EU’s commitment to combat climate change and transition to a more sustainable, environmentally friendly economy.
Read more at GlobeNewswire: Anavex Life Sciences Announces Positive up to 4-Years Oral